Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

28
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
28
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

27
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
27
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

2.2K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

38
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
38
Hypertension I: Introduction01:28

Hypertension I: Introduction

49
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
49
Antihypertensive Drugs: Action of Diuretics01:16

Antihypertensive Drugs: Action of Diuretics

840
Diuretics are antihypertensive drugs used to treat hypertension resulting from sodium and water retention. Sodium, vital for fluid balance and nerve or muscle function, is regulated by the kidneys through millions of nephrons. Blood enters nephrons via afferent arterioles, which branch into capillaries called glomeruli. These filter blood plasma, allowing water and solutes, like sodium ions, to pass through capillary walls into Bowman's capsule. The filtrate then flows through various...
840
このページは機械翻訳されています。他のページは英語で表示される場合があります。View in English
  1. ホーム
  2. 研究分野
  3. 生物医学と臨床科学
  4. 心血管医学と血液学
  5. 心臓病 (心血管疾患を含む)
  6. 高血圧 の 治療: 概要

高血圧 の 治療: 概要

Robert M Carey1, Andrew E Moran2, Paul K Whelton3

  • 1Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville.

JAMA
|November 8, 2022

関連する実験動画

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.4K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

832
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

276

PubMed で要約を見る

まとめ
この要約は機械生成です。

高血圧は世界中で 10億人以上の成人に影響しています ライフスタイルの変化と薬は 血圧の管理と 心血管疾患のリスクを減らすための鍵です

科学分野:

  • 心臓病と公衆衛生

背景:

  • 高血圧 (高血圧) は,世界中の10億人以上の成人に影響し,心臓発作や脳卒中などの心血管疾患 (CVD) のリスクを高めています.
  • 効果的な血圧管理は,心血管疾患の罹患率と死亡率を低減するために不可欠です.

研究 の 目的:

  • 高血圧の管理に関する現在のガイドラインを概説し,ライフスタイルの変更と薬理学的治療法を強調する.
  • 心血管疾患の予防における BP 制御の重要性を強調する.

主な方法:

  • 高血圧の確立した第一線治療のレビュー.
  • ダイエット,運動,アルコールの消費を含むライフスタイルの変更についての議論.
  • 推奨薬剤とBP目標値の概要

主要な成果:

  • ライフスタイルの変更は高血圧管理の基石であり,薬物療法も補完します.
  • ファーストラインの薬には,チアジド利尿薬,ACE阻害剤/ARB,およびカルシウムチャネル阻害剤が含まれます.
  • 血圧目標の達成はCVDのリスクを大幅に低下させ,SBPの10mmHgの減少はCVDのリスクを20~30%低下させる.

結論:

  • 高血圧は世界的な健康問題であり,包括的な管理戦略が必要です.
  • 効果的な血圧管理には ライフスタイルの変化と 根拠に基づいた薬剤療法が不可欠です

関連する実験動画

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.4K
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

832
Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
04:37

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension

Published on: June 6, 2025

276
  • 効果が証明されているにもかかわらず,米国では高血圧患者の有意な割合が治療不足のままである.